Resting mast cell signature linked to improved outcomes in HR+HER2- breast cancer
Breast cancer remains the most frequently diagnosed malignancy among women worldwide and is responsible for more than 650,000 deaths each ...
Breast cancer remains the most frequently diagnosed malignancy among women worldwide and is responsible for more than 650,000 deaths each ...
For years, cancer research has treated tumor cells as relatively stable enemies: cells that multiply, spread and acquire resistance through ...
Breast tumours may contain hidden “hibernation zones” where cancer cells stop dividing, evade chemotherapy and wait for an opportunity to ...
A new study is turning the microscopic “how it grows” question in colorectal cancer liver metastases into a measurable molecular ...
Tertiary lymphoid structures (TLSs)—immune-cell aggregates that form in many solid tumours—have been linked to better outcomes from immune checkpoint blockade. ...
A team investigating how tumors respond to immunotherapy reports that complement component C3 plays a decisive role—but only when it ...
A new study in Nature Communications reveals how cancer cells can use the body’s own defenses against them. The work, ...
A groundbreaking study has unveiled new insights into the complex biology of cancer-associated fibroblasts (CAFs) within triple-negative breast cancer (TNBC), ...
In a groundbreaking study that could have significant implications for cancer treatment, researchers have uncovered a surprising link between polyvinyl ...
A groundbreaking study from NYU Langone Health and its Perlmutter Cancer Center elucidates a novel mechanism by which lung tumors ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine